肾上皮样血管平滑肌脂肪瘤临床诊治分析  

Diagnosis and therapy of renal epithelioid angiomyolipoma

作　　者：王科峰[1] 王鹏[1] 张墨[1] 刘学锋[1] 王侠[1] 吴斌[1] 

机构地区：[1]中国医科大学附属盛京医院泌尿外科,辽宁沈阳110004

出　　处：《现代肿瘤医学》2014年第3期607-609,共3页Journal of Modern Oncology

摘　　要：目的:探讨肾上皮样血管平滑肌脂肪瘤(REA)的临床特点和诊治方法。方法:回顾性分析2007年3月-2013年1月我院收治的13例REA的临床资料,分析其临床、病理、治疗和预后的特点。结果:术前诊断为肾血管平滑肌脂肪瘤(AML)7例。所有患者均行手术治疗,术后免疫组化分析支持REA诊断。9例获得随访,随访时间4-74个月,平均31个月。无瘤存活6例。结论:REA是一种少见的具有恶性潜能的肿瘤,诊断需要与肾细胞癌(RCC)相鉴别。免疫组化能够确诊,术后需要密切随访。Objective：To investigate the clinical characteristics,diagnosis and treatment of renal epithelioid angio- myolipoma（REA）. Methods：A retrospective study was accomplished on 13 patients of REA ll＇om March 2007 to Jan- uary 2013. The clinical findings,pathologic features,treatment and prognostic characteristics were evaluated. Results： Seven cases were diagnosed as renal angiomyolipoma（AML） preoperatively. All the cases were treated by surgery, Im- munohistochemical analysis supported REA after surgery. 9 cases were followed for 31 months （ranging 4 - 74 months）. 6 patients survived with tumor- free. Conclusion：REA is a rarely potentially malignant neoplasm, it needs to identify with renal cell carcinoma before diagnosis, Immunohistochemical staining can be used for diagnosis. Follow- ing up closely is needed.

关 键 词：肾 肿瘤 上皮样 血管平滑肌脂肪瘤 

分 类 号：R737.12[医药卫生—肿瘤]